SB
Sunshine Biopharma, Inc.
SBFM · NASDAQ
$0.90 +9.73% (+$0.08)
1M -22.43%
Market Cap $2.00M
P/E Ratio -
Div. Yield -
ROE 24.23%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.07x
P/S 0.06x
PEG N/A
Growth
86 /100
Growing Book val. growth 2.13%
Rev. growth 102.91%
FCF growth N/A
Profitability
11 /100
Weak FCF margin 13.01%
Op. margin 14.71%
Gross margin 29.80%
Quality
13 /100
Poor Asset turnover 1.05x
ROA 17.34%
ROIC 19.32%
Debt
100 /100
Low Current ratio 5.46x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
43 /100
Moderate Profitable years 0
EPS volatility 8.81%
Beta 1.32x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SBFM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Steve N. Slilaty
Employees
50
Headquarters
Fort Lauderdale
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report